ISSN 1006-298X      CN 32-1425/R

导航

肾脏病与透析肾移植杂志 ›› 2023, Vol. 32 ›› Issue (5): 481-486.DOI: 10.3969/j.issn.1006-298X.2023.05.017

• • 上一篇    下一篇

血液透析中的血液相容性

HUANG Li, GE Yongchun   

  • 出版日期:2023-10-28 发布日期:2023-10-25

Hemocompatibility in haemodialysis

  • Online:2023-10-28 Published:2023-10-25

摘要: 血液相容性是生物相容性的一种,是血液对外源性物质或材料产生合乎要求的反应,用于评价生物材料与血液接触产生预期的临床效应,且不引起人体不良反应。生物材料的血液相容性评价包括其促血栓形成、引起补体激活、白细胞活化、炎症因子释放的能力。提高血液相容性可改善血液透析患者预后,主要措施包括选择生物相容性较好的透析膜、个体化抗凝、减少体外循环机械应力、减少气血接触和上机前充分预冲等。


关键词: 血液透析, 生物相容性, 血液相容性

Abstract: Hemocompatibility is one category of biocompatibility to evaluate the quality of blood-contacting device applications and therapies. Criteria of hemocompatibility of hemodialysis focus on thrombogenicity, complement activation, cells activation and cytokine generation. Approaches to improve hemocompatibility include usage of membrane with improved profiles, improving design and adequate rinse of extracorporeal circuit, minimize blood-air interfaces, and individuation of anticoagulation, which can improve outcomes of hemo dialysis patients.


Key words: haemodialysis, biocompatibility, hemocompatibility